Recently, Colombo et al. evaluated beta cell function, insulin clearance and insulin sensitivity in 13 CF patients homozygous for Phe508del CFTR mutation after 1 year of Lumacaftor/Ivacaftor treatment in comparison to untreated patients with the same genotype [27]. The gene discussed is CFTR; the disease is cystic fibrosis.